UP!
Hemispherx Biopharma (AMEX: HEB) is a biopharmaceutical company based in Philadelphia, Pennsylvania. Founded in 1990, the company has 32 employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for chronic fatigue syndrome.
On April 3, 2001, Hemispherx Biopharma, Inc. adjusted and restated its 1999 financial statements to reflect charges relating to an extension of the exercise period to certain warrants as of February 1999.
On April 3, 2006, Hemispherx Biopharma, Inc. restated financial results for 2003 and 2004 due to accounting mistakes related to debentures and warrants issued between March 2003 and August 2005.
| 7856-03-21 | ||||
| 6393-02-14 | ||||
| 5080-04-02 | ||||
| 5000-03-19 | ||||
| 3573-02-26 | ||||
| 2220-03-31 | ||||
| 2015-04-02 | Initiated Coverage | Midtown Partners | Strong-Buy | $1.45 |
| 2014-01-21 | Initiated | Chardan Capital Markets | Buy | $3 |
| 2014-01-21 | Initiated Coverage | Chardan Capital | Buy | $3.00 |
| 2007-12-10 | Downgrade | Boenning & Scattergood | Market Outperform to Market Perform | |
| 1970-01-01 | ||||
| 0689-03-09 |
| 7856-03-21 | ||||
| 6393-02-14 | ||||
| 5080-04-02 | ||||
| 5000-03-19 | ||||
| 3573-02-26 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HEB 4 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 0.48M |
| Investors Capital Advisory Services | 10000 |
| BlackRock Fund Advisors | 6904 |
| BLACKROCK ADVISORS LLC | 5727 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| CARTER WILLIAM A Chief Executive Officer | 0.65% (1225585) | HEB / |
| KIANI IRAJ EGHBAL | 0.33% (630886) | HEB / |
| Equels Thomas K. | 0.28% (524919) | HEB / |
| Lander Russel J VP of Process/QualityAssurance | 0.11% (207983) | HEB / |
| MITCHELL WILLIAM M | 0.11% (199661) | HEB / |
| Bernhardt Charles Thomas III CFO | 0.09% (177420) | HEB / |
| Appelrouth Stewart | 0.06% (115750) | HEB / |
| PIANI RICHARD | 0.03% (56818) | HEB / |
| STRAYER DAVID R Medical Director | 0.02% (41804) | HEB / |
| ETHERIDGE RANSOM Secretary & General Counsel | 0.02% (35714) | HEB / |
| Springate Wayne S. Vice President of Operations | 0.02% (32514) | HEB / |
| Pascale Adam Chief Accounting Officer | 0.01% (27389) | HEB / |
| Rodino Peter W. III | 0.01% (15873) | HEB / |
UM